Cash flow Alligo AB

Stocks

ALLIGO B

SE0009922305

Industrial Machinery & Equipment

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2026-06-26 EDT			5-day change	1st Jan Change
125.20 ^SEK	-0.95%		-6.71%	-2.34%

06-12	Handelsbanken Fonder increases stake in Alligo to just over 5 percent	FW
06-08	Espiria Sweden Small Cap rose 6.1 percent in May - Hansa Biopharma contributed positively	FW

3e83efc15.yLR9Lw_E4W4FtGOsby-WV3jn6PthSHywYQTn27aC6yk.jfkfflmxihZ8xxb1PALYBkyJjLJULzfUGG-9reHX2Buy-zNBWqPZPGOFCA

Published financial data: ALLIGO AB

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	8.48B	9.21B	9.34B	9.33B	9.55B
Other Revenues, Total	18M	40M	42M	23M	3M
Total Revenues	8.49B	9.25B	9.38B	9.36B	9.55B
Cost of Goods Sold, Total	4.99B	5.48B	5.47B	5.53B	5.63B
Gross Profit	3.51B	3.77B	3.91B	3.82B	3.93B
Selling General & Admin Expenses, Total	1.66B	1.74B	1.81B	1.87B	1.96B
Depreciation & Amortization - (IS)	563M	486M	533M	608M	608M
Other Operating Expenses	863M	871M	821M	837M	880M
Other Operating Expenses, Total	3.09B	3.1B	3.16B	3.32B	3.45B
Operating Income	420M	669M	749M	509M	479M
Interest Expense, Total	-39M	-58M	-123M	-155M	-141M
Interest And Investment Income	-	-	13M	21M	29M
Net Interest Expenses	-39M	-58M	-110M	-134M	-112M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	7M	5M	-	4M	-
Other Non Operating Income (Expenses)	-9M	1M	-4M	-12M	-4M
EBT, Excl. Unusual Items	379M	617M	635M	367M	363M
Merger & Related Restructuring Charges	-1M	-5.3M	-4M	-10M	-2M
Asset Writedown	-	-	-	-	-6M
Insurance Settlements	1M	-	3M	2M	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	379M	612M	634M	359M	355M
Income Tax Expense	88M	131M	137M	80M	86M
Earnings From Continuing Operations	291M	481M	497M	279M	269M
Earnings Of Discontinued Operations	139M	3.58B	-	-	-
Net Income to Company	430M	4.06B	497M	279M	269M
Minority Interest	-1M	-1M	-6M	-5M	-8M
Net Income - (IS)	429M	4.06B	491M	274M	261M
Net Income to Common Incl Extra Items	429M	4.06B	491M	274M	261M
Net Income to Common Excl. Extra Items	290M	480M	491M	274M	261M
Per Share Items
Net EPS - Basic	8.5	80.45	9.76	5.47	5.21
Basic EPS - Continuing Operations	5.75	9.51	9.76	5.47	5.21
Basic Weighted Average Shares Outstanding	50.45M	50.48M	50.3M	50.06M	50.08M
Net EPS - Diluted	8.5	80.45	9.76	5.47	5.21
Diluted EPS - Continuing Operations	5.75	9.51	9.76	5.47	5.21
Diluted Weighted Average Shares Outstanding	50.46M	50.48M	50.3M	50.06M	50.08M
Normalized Basic EPS	4.68	7.62	7.77	4.48	4.37
Normalized Diluted EPS	4.67	7.62	7.77	4.48	4.37
Dividend Per Share	1.75	3	3.5	2	2.2
Payout Ratio	17.72	2.17	30.75	63.87	38.31
Supplemental Items
EBITDA	653M	837M	919M	702M	686M
EBITA	524M	768M	843M	606M	586M
EBIT	420M	669M	749M	509M	479M
EBITDAR	673M	860M	942M	728M	709M
Total Revenues (As Reported)	8.51B	9.33B	9.46B	9.44B	9.64B
Effective Tax Rate - (Ratio)	23.22	21.41	21.61	22.28	24.23
Total Current Taxes	96M	111M	120M	84M	84M
Total Deferred Taxes	-12M	20M	17M	-4M	2M
Normalized Net Income	236M	385M	391M	224M	219M
Interest on Long-Term Debt	15M	19M	31M	44M	48M
Non-Cash Pension Expense	-	-	-	-	-
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	1M	-	-	-	-
Net Rental Expense, Total	20M	23M	23M	26M	23M
Imputed Operating Lease Interest Expense	2.39M	4.01M	7.83M	9.78M	7.2M
Imputed Operating Lease Depreciation	17.61M	18.99M	15.17M	16.22M	15.8M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	286M	215M	382M	670M	486M
Total Cash And Short Term Investments	286M	215M	382M	670M	486M
Accounts Receivable, Total	1.16B	1.28B	1.17B	1.19B	1.23B
Other Receivables	131M	145M	143M	193M	202M
Total Receivables	1.29B	1.43B	1.32B	1.38B	1.43B
Inventory	1.86B	2.28B	2.35B	2.47B	2.48B
Prepaid Expenses	39M	16M	37M	26M	34M
Other Current Assets, Total	1.07B	125M	63M	47M	29M
Total Current Assets	4.55B	4.06B	4.15B	4.6B	4.46B
Gross Property Plant And Equipment	1.77B	1.88B	2.22B	2.37B	2.48B
Accumulated Depreciation	-303M	-326M	-394M	-476M	-536M
Net Property Plant And Equipment	1.47B	1.56B	1.83B	1.9B	1.95B
Long-term Investments	-	-	2M	2M	2M
Goodwill	1.46B	1.56B	1.64B	1.96B	2.03B
Other Intangibles, Total	1.12B	1.09B	1.08B	1.12B	1.12B
Deferred Tax Assets Long-Term	75M	67M	59M	62M	75M
Other Long-Term Assets, Total	14M	24M	29M	33M	25M
Total Assets	8.68B	8.36B	8.79B	9.67B	9.66B
Liabilities
Accounts Payable, Total	1.14B	1.07B	1.02B	1.14B	1.09B
Accrued Expenses, Total	532M	558M	521M	509M	476M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	124M	-	-	9M	2M
Current Portion of Leases	339M	352M	398M	443M	471M
Current Income Taxes Payable	8M	55M	27M	12M	17M
Unearned Revenue Current, Total	8M	6M	9M	7M	9M
Other Current Liabilities	582M	85M	77M	154M	132M
Total Current Liabilities	2.74B	2.13B	2.05B	2.27B	2.19B
Long-Term Debt	1.42B	1.75B	1.83B	2.3B	2.26B
Long-Term Leases	674M	661M	793M	826M	898M
Pension & Other Post Retirement Benefits	-	-	-	-	-
Deferred Tax Liability Non Current	349M	363M	381M	408M	418M
Other Non Current Liabilities	50M	52M	94M	119M	94M
Total Liabilities	5.23B	4.95B	5.15B	5.92B	5.86B
Common Stock, Total	102M	102M	102M	102M	102M
Retained Earnings	3.33B	3.26B	3.51B	3.6B	3.76B
Comprehensive Income and Other	-5M	48M	-3M	13M	-111M
Total Common Equity	3.43B	3.41B	3.61B	3.72B	3.75B
Minority Interest	19M	5M	26M	37M	45M
Total Equity	3.45B	3.41B	3.64B	3.76B	3.8B
Total Liabilities And Equity	8.68B	8.36B	8.79B	9.67B	9.66B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	50.48M	50.48M	50.05M	50.07M	50.09M
ECS Total Common Shares Outstanding	50.48M	50.48M	50.05M	50.07M	50.09M
Book Value / Share	67.93	67.51	72.19	74.28	74.89
Tangible Book Value	852M	753M	890M	636M	602M
Tangible Book Value Per Share	16.88	14.92	17.78	12.7	12.02
Total Debt	2.56B	2.76B	3.02B	3.57B	3.63B
Net Debt	2.27B	2.55B	2.64B	2.9B	3.14B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	-	-	-
Debt Equivalent Oper. Leases	160M	184M	184M	208M	184M
Minority Interest, Total (Incl. Fin. Div)	19M	5M	26M	37M	45M
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Finished Goods, Total	1.86B	2.28B	2.35B	2.47B	2.48B
Land - (BS)	-	-	-	-	-
Buildings, Total	304M	307M	309M	322M	336M
Machinery, Total	419M	484M	594M	700M	725M
Full Time Employees	2.32K	2.37K	2.44K	2.62K	2.76K
Accumulated Allowance for Doubtful Accounts (Supple)	41M	48M	28M	20M	19M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	429M	4.06B	491M	274M	261M
Depreciation & Amortization - CF	512M	387M	439M	511M	501M
Amortization of Goodwill and Intangible Assets - (CF)	104M	99M	94M	97M	107M
Depreciation & Amortization, Total	616M	486M	533M	608M	608M
Amortization of Deferred Charges, Total - (CF)	1M	-	-	-	-
(Gain) Loss From Sale Of Asset	7M	-	1M	-	1M
Asset Writedown & Restructuring Costs	-	-	-	-	6M
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Net Cash From Discontinued Operations	176M	-59M	-	-	-
Other Operating Activities, Total	-108M	-3.5B	-5M	-55M	47M
Change In Accounts Receivable	-279M	-100M	176M	80M	-55M
Change In Inventories	-282M	-349M	-83M	6M	-4M
Change in Other Net Operating Assets	383M	-91M	-120M	39M	-66M
Cash from Operations	943M	448M	993M	952M	798M
Capital Expenditure	-114M	-108M	-172M	-93M	-93M
Sale of Property, Plant, and Equipment	2M	4M	1M	8M	2M
Cash Acquisitions	-31M	-144M	-126M	-425M	-296M
Divestitures	-23M	-	-	-5M	-
Sale (Purchase) of Intangible assets	-44M	-38M	-39M	-22M	-21M
Investment in Marketable and Equity Securities, Total	-15M	-10M	-5M	-4M	9M
Other Investing Activities, Total	-120M	-	-	-	-
Cash from Investing	-345M	-296M	-341M	-541M	-399M
Long-Term Debt Issued, Total	-	1.87B	92M	460M	107M
Total Debt Issued	-	1.87B	92M	460M	107M
Long-Term Debt Repaid, Total	-527M	-2.06B	-378M	-405M	-582M
Total Debt Repaid	-527M	-2.06B	-378M	-405M	-582M
Issuance of Common Stock	9M	-	-	2M	2M
Repurchase of Common Stock	-	-	-46M	-	-
Common Dividends Paid	-76M	-88M	-151M	-175M	-100M
Common & Preferred Stock Dividends Paid	-76M	-88M	-151M	-175M	-100M
Other Financing Activities, Total	-35M	-6M	-	1M	-
Cash from Financing	-629M	-281M	-483M	-117M	-573M
Foreign Exchange Rate Adjustments	1M	-1M	-2M	-6M	-10M
Net Change in Cash	-30M	-130M	167M	288M	-184M
Supplemental Items
Cash Interest Paid	44M	58M	124M	157M	143M
Cash Income Tax Paid (Refund)	144M	50M	141M	131M	78M
Levered Free Cash Flow	158M	636M	672M	719M	559M
Unlevered Free Cash Flow	182M	672M	749M	816M	647M
Change In Net Working Capital	539M	86M	41M	-5M	146M
Net Debt Issued / Repaid	-527M	-187M	-286M	55M	-475M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.18	4.91	5.46	3.45	3.1
Return on Total Capital	4.48	6.87	7.29	4.55	4.06
Return On Equity %	8.96	14.02	14.1	7.55	7.12
Return on Common Equity	8.97	14.04	13.99	7.47	6.99
Margin Analysis
Gross Profit Margin %	41.28	40.73	41.7	40.88	41.09
SG&A Margin	19.55	18.83	19.27	20	20.5
EBITDA Margin %	7.69	9.05	9.8	7.5	7.18
EBITA Margin %	6.17	8.3	8.99	6.48	6.13
EBIT Margin %	4.95	7.23	7.99	5.44	5.01
Income From Continuing Operations Margin %	3.43	5.2	5.3	2.98	2.82
Net Income Margin %	5.05	43.9	5.24	2.93	2.73
Net Avail. For Common Margin %	3.41	5.19	5.24	2.93	2.73
Normalized Net Income Margin	2.78	4.16	4.17	2.4	2.29
Levered Free Cash Flow Margin	1.86	6.88	7.17	7.69	5.85
Unlevered Free Cash Flow Margin	2.15	7.27	7.99	8.72	6.78
Asset Turnover
Asset Turnover	1.03	1.09	1.09	1.01	0.99
Fixed Assets Turnover	5.81	6.12	5.54	5.02	4.97
Receivables Turnover (Average Receivables)	7.33	7.53	7.6	7.91	7.91
Inventory Turnover (Average Inventory)	2.76	2.65	2.37	2.3	2.27
Short Term Liquidity
Current Ratio	1.66	1.91	2.02	2.03	2.03
Quick Ratio	0.58	0.77	0.83	0.9	0.87
Operating Cash Flow to Current Liabilities	0.34	0.21	0.48	0.42	0.36
Days Sales Outstanding (Average Receivables)	49.79	48.48	48.05	46.29	46.16
Days Outstanding Inventory (Average Inventory)	132.36	137.5	154.33	159.44	160.58
Average Days Payable Outstanding	77.78	68.46	68.75	69.65	71.89
Cash Conversion Cycle (Average Days)	104.37	117.52	133.63	136.08	134.85
Long Term Solvency
Total Debt/Equity	74.19	80.93	83.04	95.13	95.6
Total Debt / Total Capital	42.59	44.73	45.37	48.75	48.88
LT Debt/Equity	60.76	70.61	72.11	83.09	83.14
Long-Term Debt / Total Capital	34.88	39.03	39.39	42.58	42.5
Total Liabilities / Total Assets	60.27	59.19	58.59	61.17	60.69
EBIT / Interest Expense	10.77	11.54	6.09	3.28	3.4
EBITDA / Interest Expense	26.56	19.92	10.42	7.21	7.71
(EBITDA - Capex) / Interest Expense	23.64	18.06	9.02	6.61	7.05
Total Debt / EBITDA	2.47	2.39	2.36	3.2	3.34
Net Debt / EBITDA	2.19	2.2	2.06	2.6	2.89
Total Debt / (EBITDA - Capex)	2.77	2.64	2.72	3.49	3.65
Net Debt / (EBITDA - Capex)	2.46	2.43	2.38	2.83	3.16
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	12.13	9.51	1.36	-0.22	2.12
Gross Profit, 1 Yr. Growth %	21.23	8.87	3.77	-2.17	2.64
EBITDA, 1 Yr. Growth %	31.92	40.02	10.46	-23.28	-0.87
EBITA, 1 Yr. Growth %	32.32	46.9	10.48	-27.77	-1.68
EBIT, 1 Yr. Growth %	39.53	59.74	12.8	-31.68	-4.01
Earnings From Cont. Operations, 1 Yr. Growth %	46.23	65.29	3.33	-43.86	-3.58
Net Income, 1 Yr. Growth %	52.13	846.62	-87.91	-44.2	-4.74
Normalized Net Income, 1 Yr. Growth %	47.77	63.58	2.46	-42.23	0.34
Diluted EPS Before Extra, 1 Yr. Growth %	29.9	65.43	2.64	-43.96	-4.75
Accounts Receivable, 1 Yr. Growth %	1.04	10.59	-8.72	1.28	3.37
Inventory, 1 Yr. Growth %	5.39	22.58	3.21	5.24	0.4
Net Property, Plant and Equip., 1 Yr. Growth %	0.62	6.13	17.41	3.83	2.53
Total Assets, 1 Yr. Growth %	11.1	-3.63	5.06	10.08	-0.17
Tangible Book Value, 1 Yr. Growth %	236.76	-11.62	18.19	-28.54	-5.35
Common Equity, 1 Yr. Growth %	12.91	-0.61	6.02	2.93	0.86
Cash From Operations, 1 Yr. Growth %	-20.82	-42.34	121.65	-4.13	-16.18
Capital Expenditures, 1 Yr. Growth %	-11.63	-0.92	59.26	-45.93	0
Levered Free Cash Flow, 1 Yr. Growth %	-	486.23	6.24	7.39	-21.56
Unlevered Free Cash Flow, 1 Yr. Growth %	-	405.97	11.98	9.31	-20.06
Dividend Per Share, 1 Yr. Growth %	-12.5	71.43	16.67	-42.86	10
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	10.52	5.35	0.57	0.94
Gross Profit, 2 Yr. CAGR %	-	14.14	6.29	0.75	0.2
EBITDA, 2 Yr. CAGR %	-	30.06	23.97	-8.14	-13.41
EBITA, 2 Yr. CAGR %	-	39.29	26.96	-10.88	-16.43
EBIT, 2 Yr. CAGR %	-	49.12	33.7	-12.45	-19.82
Earnings From Cont. Operations, 2 Yr. CAGR %	-	55.47	30.69	-23.84	-26.43
Net Income, 2 Yr. CAGR %	-	279.48	6.98	-74.02	-27.09
Normalized Net Income, 2 Yr. CAGR %	-	55.27	28.9	-23.31	-24.93
Diluted EPS Before Extra, 2 Yr. CAGR %	-	46.59	30.31	-24.15	-26.94
Accounts Receivable, 2 Yr. CAGR %	-	5.71	0.47	-3.85	2.32
Inventory, 2 Yr. CAGR %	-	13.66	12.48	4.22	2.79
Net Property, Plant and Equip., 2 Yr. CAGR %	-	3.34	11.63	10.41	3.18
Total Assets, 2 Yr. CAGR %	-	3.47	0.62	7.54	4.83
Tangible Book Value, 2 Yr. CAGR %	-	72.52	2.21	-8.1	-17.76
Common Equity, 2 Yr. CAGR %	-	5.93	2.65	4.46	1.89
Cash From Operations, 2 Yr. CAGR %	-	-38.67	13.05	45.77	-10.35
Capital Expenditures, 2 Yr. CAGR %	-	-8.5	25.62	-7.2	-26.47
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	148.91	6.62	-8.62
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	137.44	10.45	-6.88
Dividend Per Share, 2 Yr. CAGR %	-	22.47	41.42	-18.35	-20.72
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	7.38	3.46	1.08
Gross Profit, 3 Yr. CAGR %	-	-	10.58	3.39	1.38
EBITDA, 3 Yr. CAGR %	-	-	22.91	5.49	-6.23
EBITA, 3 Yr. CAGR %	-	-	28.64	5.03	-8.42
EBIT, 3 Yr. CAGR %	-	-	35.51	6.7	-10.31
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	35.68	-1.39	-17.61
Net Income, 3 Yr. CAGR %	-	-	20.3	-13.88	-59.94
Normalized Net Income, 3 Yr. CAGR %	-	-	34.79	-1.57	-16.91
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	30.17	-1.64	-18.17
Accounts Receivable, 3 Yr. CAGR %	-	-	0.66	0.74	-1.5
Inventory, 3 Yr. CAGR %	-	-	10.06	10.01	2.93
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	7.83	8.97	7.72
Total Assets, 3 Yr. CAGR %	-	-	4	3.68	4.91
Tangible Book Value, 3 Yr. CAGR %	-	-	52.09	-9.29	-7.19
Common Equity, 3 Yr. CAGR %	-	-	5.96	2.74	3.25
Cash From Operations, 3 Yr. CAGR %	-	-	-5.88	7.01	21.22
Capital Expenditures, 3 Yr. CAGR %	-	-	10.06	-5.15	-4.86
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	87.85	-4.03
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	83.13	-1.09
Dividend Per Share, 3 Yr. CAGR %	-	-	20.51	4.55	-9.82
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	4.75
Gross Profit, 5 Yr. CAGR %	-	-	-	-	6.3
EBITDA, 5 Yr. CAGR %	-	-	-	-	6.74
EBITA, 5 Yr. CAGR %	-	-	-	-	8.15
EBIT, 5 Yr. CAGR %	-	-	-	-	9.74
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	6.21
Net Income, 5 Yr. CAGR %	-	-	-	-	-1.54
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	6.52
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	3.32
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	1.32
Inventory, 5 Yr. CAGR %	-	-	-	-	7.1
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	5.94
Total Assets, 5 Yr. CAGR %	-	-	-	-	4.33
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	18.93
Common Equity, 5 Yr. CAGR %	-	-	-	-	4.31
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	-7.7
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	-6.33
Dividend Per Share, 5 Yr. CAGR %	-	-	-	-	1.92